Enzene Biosciences launches first manufacturing base in US

Pune-based Contract Development & Manufacturing Organisation (CDMO), Enzene Biosciences has announced the launch of its first manufacturing site in the United States, located in Hopewell (near Princeton, New Jersey). The site is expected to be ready in June 2024, and customers have already started to reserve capacities for continuous manufacturing and/or fed batch.

Designed to integrate the company’s patented EnzeneX continuous manufacturing technology platform, the plant is situated within the Princeton West Innovation Campus, at the heart of the US Northeast Corridor, within easy reach of several global biotech and pharmaceutical firms. This location is ideal for helping Enzene Biosciences serve emerging innovative, US-based biotech firms looking to benefit from the in-depth expertise in continuous manufacturing.

Spread over 54,000 square feet, this plant will also hold the distinction of being one of the only biologics-focused continuous manufacturing bases to be set up by an Indian firm in the US. The company narrowed down on New Jersey because of its long tradition of supporting pharmaceutical manufacturing excellence. There is also ample availability of highly skilled talent in the region and Enzene Inc. is confident of securing skilled labour for sustained manufacturing operations over the longer term.

Enzene Biosciences aims to gradually expand its operations across the five major markets for biologics and biosimilars, i.e. the EU, US, Canada, Australia, and Japan.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!